Mallinckrodt plc (NYSE: MNK) is -30.09% lower on its value in year-to-date trading and has touched a low of $1.00 and a high of $8.87 in the current 52-week trading range. The MNK stock was last observed hovering at around $2.44 in the recent trading session, with the current loss setting it -0.05%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $2.39, the stock is -10.20% and -19.11% below its SMA20 and SMA50 respectively. However, with a current trading volume of 0.52 million and changing -1.84% at the moment leaves the stock -26.36% off its SMA200. MNK registered -70.67% loss for a year compared to 6-month loss of -25.15%. The firm has a 50-day simple moving average (SMA 50) of $2.8176 and a 200-day simple moving average (SMA200) of $3.3704.
The stock witnessed a -13.48% gain in the last 1 month and extending the period to 3 months gives it a 36.31%, and is -12.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.71% over the week and 9.08% over the month.
Mallinckrodt plc (MNK) has around 3400 employees, a market worth around $211.96M and $3.04B in sales. Fwd P/E is 0.59. Profit margin for the company is -39.60%. Distance from 52-week low is 139.50% and -73.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.50%).
Mallinckrodt plc (MNK) Analyst Forecasts
Mallinckrodt plc quarterly earnings per share for the current quarter are estimated at $1.32 with sales reaching $635.7M over the same period.The EPS is expected to grow by 72.20% this year, but quarterly earnings will post -16.30% year-over-year. Quarterly sales are estimated to shrink -22.80% in year-over-year returns.
Mallinckrodt plc (MNK) Top Institutional Holders
296 institutions hold shares in Mallinckrodt plc (MNK), with 1.44M shares held by insiders accounting for 1.71% while institutional investors hold 98.10% of the company’s shares. The shares outstanding are 84.20M, and float is at 83.10M with Short Float at 53.72%. Institutions hold 96.43% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 7.83 million shares valued at $15.51 million. The investor’s holdings represent 9.28% of the MNK Shares outstanding. As of Mar 30, 2020, the second largest holder is Dimensional Fund Advisors LP with 6.39 million shares valued at $12.65 million to account for 7.56% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.39 million shares representing 7.56% and valued at over $12.64 million, while Deerfield Management Company, L.P. (Series C) holds 4.77% of the shares totaling 4.03 million with a market value of $7.97 million.
Mallinckrodt plc (MNK) Insider Activity
A total of 21 insider transactions have happened at Mallinckrodt plc (MNK) in the last six months, with sales accounting for 21 and purchases happening 0 times.
Mallinckrodt plc (MNK): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.33% up over the past 12 months. Teva Pharmaceutical Industries Limited (TEVA) is 22.25% up on the 1-year trading charts. Short interest in the company’s stock has fallen -2.87% from the last report on May 14, 2020 to stand at a total of 45.93 million short shares sold with a short interest ratio of 10.42.